BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11164717)

  • 1. Intensive and timely chemotherapy, the key of success in testicular cancer.
    Fléchon A; Culine S; Droz JP
    Crit Rev Oncol Hematol; 2001 Jan; 37(1):35-46. PubMed ID: 11164717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
    Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Salvage High-Dose Chemotherapy in Relapsed Male Germ Cell Tumors.
    Oing C; Lorch A
    Oncol Res Treat; 2018; 41(6):365-369. PubMed ID: 29843143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: the French experience.
    Fléchon A; Biron P; Droz JP
    Int J Cancer; 1999 Dec; 83(6):844-7. PubMed ID: 10597208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy for male germ cell tumor.
    Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
    Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
    Einhorn LH; Williams SD; Chamness A; Brames MJ; Perkins SM; Abonour R
    N Engl J Med; 2007 Jul; 357(4):340-8. PubMed ID: 17652649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage high-dose chemotherapy for germ cell tumors.
    Feldman DR; Powles T
    Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
    Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
    Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
    Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of testicular germ cell tumors relapse].
    Carbonnaux M; Vinceneux A; Peyrat P; Fléchon A
    Bull Cancer; 2020 Sep; 107(9):912-924. PubMed ID: 32653158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current pharmacotherapy for testicular germ cell cancer.
    Alsdorf W; Seidel C; Bokemeyer C; Oing C
    Expert Opin Pharmacother; 2019 May; 20(7):837-850. PubMed ID: 30849243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil.
    Polho GB; Cunha MT; Coelho MHM; Almeida-Silva J; Hidalgo Filho CM; Xavier EM; Crusoe NS; Atanazio MJ; de Vasconcellos VF; Horita VN; Freitas GF; Muniz DQ; Rocha V; Mota JM
    Clin Genitourin Cancer; 2024 Jun; 22(3):102083. PubMed ID: 38658209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Third-line chemotherapy and novel agents for metastatic germ cell tumors.
    Veenstra CM; Vaughn DJ
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):577-91, ix. PubMed ID: 21570610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
    Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
    Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose chemotherapy for germ cell tumors: do we have a model?
    Necchi A; Lanza F; Rosti G; Martino M; Farè E; Pedrazzoli P;
    Expert Opin Biol Ther; 2015 Jan; 15(1):33-44. PubMed ID: 25243977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should high dose chemotherapy with, or without, autologous bone marrow transplant be included in the primary treatment of testicular cancer? Round table discussion.
    Grigor KM; Schmoll HJ
    Eur Urol; 1993; 23(1):240-4. PubMed ID: 8386655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-Dose Chemotherapy and Autologous Stem Cell Transplant.
    Adra N; Abonour R
    Urol Clin North Am; 2019 Aug; 46(3):439-448. PubMed ID: 31277738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors.
    Bokemeyer C
    Oncology; 1998; 55(3):177-88. PubMed ID: 9560052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
    Motzer RJ; Nichols CJ; Margolin KA; Bacik J; Richardson PG; Vogelzang NJ; Bajorin DF; Lara PN; Einhorn L; Mazumdar M; Bosl GJ
    J Clin Oncol; 2007 Jan; 25(3):247-56. PubMed ID: 17235042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic treatment of germ cell tumors: standard of care and recent developments.
    Oing C; Seidel C; von Amsberg G; Oechsle K; Bokemeyer C
    Expert Opin Pharmacother; 2016; 17(4):545-60. PubMed ID: 26630452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.